Found: 159
Select item for more details and to access through your institution.
Breeding for brown plant hopper resistance in rice: recent updates and future perspectives.
- Published in:
- Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09966-9
- By:
- Publication type:
- Article
Direct to Cancer: A new initiative to enhance the author experience.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 20, p. 3404, doi. 10.1002/cncr.35430
- By:
- Publication type:
- Article
Real-World Effectiveness of Systemic Agents Approved for Advanced Non-Small Cell Lung Cancer: A SEER-Medicare Analysis.
- Published in:
- Oncologist, 2013, v. 18, n. 5, p. 600, doi. 10.1634/theoncologist.2012-0480
- By:
- Publication type:
- Article
The Role of the Taxanes in the Treatment of Older Patients with Advanced Stage Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2009, v. 14, n. 4, p. 412, doi. 10.1634/theoncologist.2008-0190
- By:
- Publication type:
- Article
Systemic Chemotherapy for Advanced Non-Small Cell Lung Cancer: Recent Advances and Future Directions.
- Published in:
- Oncologist, 2008, v. 13, p. 5, doi. 10.1634/theoncologist.13-S1-5
- By:
- Publication type:
- Article
Systemic Chemotherapy for Advanced Non-Small Cell Lung Cancer: Recent Advances and Future Directions.
- Published in:
- Oncologist, 2008, v. 13, p. 5, doi. 10.1634/theoncologist.13-S1-5
- By:
- Publication type:
- Article
Targeting Transient Receptor Potential Melastatin‐2 (TRPM2) Enhances Therapeutic Efficacy of Third Generation EGFR Inhibitors against EGFR Mutant Lung Cancer.
- Published in:
- Advanced Science, 2024, v. 11, n. 35, p. 1, doi. 10.1002/advs.202310126
- By:
- Publication type:
- Article
Lung cancer: New biological insights and recent therapeutic advances.
- Published in:
- CA: A Cancer Journal for Clinicians, 2011, v. 61, n. 2, p. 91, doi. 10.3322/caac.20102
- By:
- Publication type:
- Article
Population Pharmacokinetics of Pegylated Liposomal CKD-602 (S-CKD602) in Patients With Advanced Malignancies.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 2, p. 180, doi. 10.1177/0091270010394851
- By:
- Publication type:
- Article
Diallyl Trisulfide Selectively Causes Bax- and Bak-Mediated Apoptosis in Human Lung Cancer Cells.
- Published in:
- Environmental & Molecular Mutagenesis, 2009, v. 50, n. 3, p. 201, doi. 10.1002/em.20431
- By:
- Publication type:
- Article
Gender and Ethnic Disparities in Incidence and Survival of Squamous Cell Carcinoma of the Oral Tongue, Base of Tongue, and Tonsils: A Surveillance, Epidemiology and End Results Program-Based Analysis.
- Published in:
- Oncology, 2011, v. 81, n. 1, p. 12, doi. 10.1159/000330807
- By:
- Publication type:
- Article
Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. 342, doi. 10.1093/oncolo/oyad335
- By:
- Publication type:
- Article
A Review of Immunotherapy for Stage III and Metastatic Non‐Small Cell Lung Cancer and the Rationale for the ECOG‐ACRIN EA5181 Study.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. 523, doi. 10.1002/onco.13725
- By:
- Publication type:
- Article
Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e964, doi. 10.1634/theoncologist.2019-0661
- By:
- Publication type:
- Article
Using Metaphors to Explain Molecular Testing to Cancer Patients.
- Published in:
- Oncologist, 2017, v. 22, n. 4, p. 445, doi. 10.1634/theoncologist.2016-0270
- By:
- Publication type:
- Article
Electrocardiographic Characterization of Ramucirumab on the Corrected QT Interval in a Phase II Study of Patients With Advanced Solid Tumors.
- Published in:
- Oncologist, 2016, v. 21, n. 4, p. 402, doi. 10.1634/theoncologist.2015-0467
- By:
- Publication type:
- Article
Overexpression of the base excision repair NTHL1 glycosylase causes genomic instability and early cellular hallmarks of cancer.
- Published in:
- Nucleic Acids Research, 2018, v. 46, n. 9, p. 4515, doi. 10.1093/nar/gky162
- By:
- Publication type:
- Article
Co-Occurrence Conundrum: Brain Metastases from Lung Adenocarcinoma, Radiation Necrosis, and Gliosarcoma.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 487, doi. 10.1159/000514297
- By:
- Publication type:
- Article
Impact of Disease and Treatment Response in Drug–Drug Interaction Studies: Osimertinib and Simvastatin in Advanced Non‐Small Cell Lung Cancer.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 1, p. 41, doi. 10.1111/cts.12688
- By:
- Publication type:
- Article
Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis.
- Published in:
- Head & Neck, 2019, v. 41, n. 5, p. 1490, doi. 10.1002/hed.25379
- By:
- Publication type:
- Article
The role of targeted agents in the treatment of elderly patients with non-small cell lung cancer (NSCLC).
- Published in:
- 2008
- By:
- Publication type:
- journal article
Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589).
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 9, p. 2024, doi. 10.1002/cncr.32744
- By:
- Publication type:
- Article
ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589).
- Published in:
- 2020
- By:
- Publication type:
- journal article
A new standard of care for patients with surgically unresectable stage III non-small cell lung cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Immune checkpoint inhibitors in advanced non-small cell lung cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature.
- Published in:
- 2018
- By:
- Publication type:
- journal article
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3476, doi. 10.1002/cncr.30763
- By:
- Publication type:
- Article
Discussing molecular testing in oncology care: Comparing patient and physician information preferences.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial/ethnic dissimilarities in participation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vismodegib or cixutumumab in combination with standard chemotherapy for patients with extensive-stage small cell lung cancer: A trial of the ECOG-ACRIN Cancer Research Group (E1508).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Trends, predictors, and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Lung cancer in China: The new frontier?
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Early detection of lung cancer in China: The immediate imperative.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Time to Divest From Tobacco-Funded Research.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 14, p. 2294, doi. 10.1002/cncr.29361
- By:
- Publication type:
- Article
Three-arm, randomized, phase 2 study of carboplatin and paclitaxel in combination with cetuximab, cixutumumab, or both for advanced non-small cell lung cancer (NSCLC) patients who will not receive bevacizumab-based therapy: An Eastern Cooperative Oncology Group (ECOG) study (E4508).
- Published in:
- 2015
- By:
- Publication type:
- journal article
The next generation of epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of lung cancer.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 8, p. E1, doi. 10.1002/cncr.29139
- By:
- Publication type:
- Article
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 24, p. 3940, doi. 10.1002/cncr.28965
- By:
- Publication type:
- Article
ALK-positive non-small cell lung cancer: Mechanisms of resistance and emerging treatment options.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 16, p. 2392, doi. 10.1002/cncr.28597
- By:
- Publication type:
- Article